Pullen Investment Management LLC Raises Holdings in American Vanguard Corporation $AVD

Pullen Investment Management LLC grew its position in shares of American Vanguard Corporation (NYSE:AVD) by 31.8% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 320,489 shares of the basic materials company’s stock after buying an additional 77,346 shares during the period. Pullen Investment Management LLC’s holdings in American Vanguard were worth $1,256,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Cerity Partners LLC purchased a new position in shares of American Vanguard during the 1st quarter valued at $48,000. American Century Companies Inc. lifted its position in shares of American Vanguard by 142.5% during the 1st quarter. American Century Companies Inc. now owns 155,355 shares of the basic materials company’s stock valued at $684,000 after buying an additional 91,283 shares during the last quarter. Hsbc Holdings PLC lifted its position in shares of American Vanguard by 11.4% during the 1st quarter. Hsbc Holdings PLC now owns 60,027 shares of the basic materials company’s stock valued at $262,000 after buying an additional 6,119 shares during the last quarter. Mackenzie Financial Corp lifted its position in shares of American Vanguard by 27.2% during the 1st quarter. Mackenzie Financial Corp now owns 130,339 shares of the basic materials company’s stock valued at $573,000 after buying an additional 27,896 shares during the last quarter. Finally, Trexquant Investment LP lifted its position in shares of American Vanguard by 415.6% during the 1st quarter. Trexquant Investment LP now owns 127,504 shares of the basic materials company’s stock valued at $561,000 after buying an additional 102,774 shares during the last quarter. Hedge funds and other institutional investors own 79.00% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on AVD. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of American Vanguard in a research report on Friday. Wall Street Zen raised American Vanguard from a “hold” rating to a “buy” rating in a report on Friday, September 5th. One analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat.com, American Vanguard presently has an average rating of “Hold” and a consensus target price of $12.00.

American Vanguard Stock Performance

Shares of AVD opened at $5.34 on Friday. The stock’s 50-day simple moving average is $5.39 and its 200 day simple moving average is $4.58. The stock has a market capitalization of $151.67 million, a price-to-earnings ratio of -1.19 and a beta of 1.26. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.00 and a current ratio of 1.91. American Vanguard Corporation has a 52-week low of $3.28 and a 52-week high of $6.68.

American Vanguard (NYSE:AVD) last issued its quarterly earnings data on Thursday, July 31st. The basic materials company reported ($0.03) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.08. American Vanguard had a negative return on equity of 26.21% and a negative net margin of 23.72%.The business had revenue of $129.31 million for the quarter, compared to analysts’ expectations of $130.00 million.

About American Vanguard

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.